T1	Intervention 22 245	highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy
T2	Intervention 391 491	protease inhibitor (PI), non-nucleoside reverse transcriptase inhibitor (NNRTI), or both are lacking
T3	Intervention 836 927	protease inhibitor (PI) strategy (PI plus nucleoside reverse transcriptase inhibitor [NRTI]
T4	Intervention 937 1019	a non-nucleoside reverse transcriptase inhibitor (NNRTI) strategy (NNRTI plus NRTI
T5	Intervention 1029 1079	or a three-class strategy (PI plus NNRTI plus NRTI
